TB, HIV targeted by student researchers
February 18, 2014 — When people who have been cured of tuberculosis (TB) re-develop the disease, are they relapsing or fighting a new strain? How often should HIV/AIDS patients be tested to see if antiretroviral treatment is working?…
Role of lung lesions in tuberculosis explored
For years scientists have sought to unravel the mystery of why about 90% of people infected by Mycobacterium tuberculosis, the bacteria that cause tuberculosis (TB), remain symptom-free for years, while the remaining 10% become sick and may die.…
New findings in battle against drug-resistant tuberculosis
Sarah Fortune, Melvin J. and Geraldine L. Glimcher associate professor of immunology and infectious diseases, on why some people infected with some "bad actor" strains of M. tuberculosis are at very high risk of getting drug resistant TB,…
New drugs, strategies needed to combat drug-resistant tuberculosis
Medical researchers from around the globe met June 28, 2012 at the Broad Institute of Harvard and MIT to discuss ways to combat the emergence of a form of drug-resistant tuberculosis. During a panel discussion at the day-long…
The promise of big data
[ Spring/Summer 2012 ] Petabytes of raw information could provide clues for everything from preventing TB to shrinking health care costs—if we can figure out how to use them. Harvard School of Public Health microbiologist Sarah Fortune went…
Why tuberculosis is so hard to cure
Coverage in Science, December 15, 2011, featuring HSPH's Sarah Fortune
Faculty members Nan Laird, Robert Blendon, and Sarah Fortune honored
December 15, 2011 -- Nan Laird was appointed the new Harvey V. Fineberg Professor of Public Health. This honor recognizes her more than 35 years developing statistical methodology, teaching, and doing applied research. Laird succeeds the first holder of…
Scientists uncover evidence on how drug-resistant tuberculosis cells form
Findings Could Lead to More Effective Treatment for Global Disease For immediate release: Thursday, December 15, 2011 Boston, MA — A new study led by Harvard School of Public (HSPH) researchers provides a novel explanation as to why some tuberculosis…
Returning home, with a plan to thwart killer TB
[ Fall 2011 ] In Kenya’s arid Wajir district, across the border from Somalia, attending school is not a given. Though some children learn to read while sitting on the floor in crowded classrooms or gathered on the…
Tuberculosis researcher Sarah Fortune receives clinical scientist development award
July 2, 2010 -- Sarah Fortune, assistant professor of immunology and infectious diseases, has been selected to receive a Clinical Scientist Development Award from the Doris Duke Charitable Foundation. The goal of the CSDA is to encourage the…
